J. I. Lieberman
#140,480
Most Influential Person Now
J. I. Lieberman's AcademicInfluence.com Rankings
J. I. Liebermanphilosophy Degrees
Philosophy
#7312
World Rank
#10506
Historical Rank
Logic
#4374
World Rank
#5657
Historical Rank

J. I. Liebermanbiology Degrees
Biology
#9932
World Rank
#13200
Historical Rank
Immunology
#607
World Rank
#627
Historical Rank
Biochemistry
#1539
World Rank
#1669
Historical Rank

Download Badge
Philosophy Biology
Why Is J. I. Lieberman Influential?
(Suggest an Edit or Addition)J. I. Lieberman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. (1975) (890)
- Alpha 1-antitrypsin Pi-types in 965 COPD patients. (1986) (272)
- Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema. (1969) (226)
- Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. (2000) (191)
- Elevation of serum angiotensin-converting enzyme in Gaucher's disease. (1976) (182)
- Serum angiotensin-converting enzyme: elevations in diabetes mellitus. (1980) (176)
- Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. (1976) (154)
- Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. (1979) (128)
- Alpha1 Antitrypsin in the Livers of Patients with Emphysema (1972) (127)
- Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. (1977) (121)
- THE SPECIFICITY AND NATURE OF SERUM‐ANGIOTENSIN‐CONVERTING ENZYME (SERUM ACE) ELEVATIONS IN SARCOIDOSIS * (1976) (106)
- Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. (1979) (90)
- Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. (1972) (87)
- Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. (1983) (78)
- Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency. (1976) (72)
- Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. (1968) (70)
- Angiotensin-converting enzyme activity in postmortem human tissues. (1983) (62)
- Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia (1995) (61)
- Inhibitors and activators of leukocytic proteases in purulent sputum. Digestion of human lung and inhibition by alpha 1-antitrypsin. (1971) (58)
- Screening for homozygous and heterozygous alpha 1-antitrypsin deficiency. Protein electrophoresis on cellulose acetate membranes. (1969) (56)
- Clinical syndromes associated with deficient lung fibrinolytic activity: I. A new concept of hyaline-membrane disease. (1959) (54)
- Identification and characteristics of the common alpha 1 -antitrypsin phenotypes. (1972) (52)
- Bronchiectasis and homozygous alpha1-antitrypsin deficiency. (1975) (49)
- Smoking and chronic obstructive lung disease in alpha-1-antitrypsin deficiency. (1971) (46)
- Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. I. Bodily trauma. (1957) (45)
- The nature of the fibrinolytic-enzyme defect in hyaline-membrane disease. (1961) (43)
- Proteolytic Enzyme Activity in Fetal Pancreas and Meconium:Demonstration of plasminogen and trypsinogen activators in pancreatic tissue (1966) (43)
- A new deficient variant of alpha1-antitrypsin (MDUARTE). Inability to detect the heterozygous state by antitrypsin phenotyping. (1976) (39)
- A deficiency of pulmonary fibrinolysis in hyaline-membrane disease. (1960) (38)
- Glutamic oxalacetic transaminase in serum and cerebrospinal fluid of patients with cerebrovascular accidents; demonstration of a blood-cerebrospinal-fluid barrier. (1957) (38)
- Serum angiotensin-converting enzyme in severe nonthyroidal illnesses associated with low serum thyroxine concentration. (1984) (37)
- Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. (1993) (36)
- Alpha-1 antitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. (1976) (36)
- Screening for heterozygous 1 -antitrypsin deficiency. 3. A provocative test with diethylstilbestrol and effect of oral contraceptives. (1971) (35)
- Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease. (1973) (34)
- Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease. (2015) (33)
- Dynamic response of alpha1-antitrypsin variants to diethylstilbestrol. (1973) (33)
- Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variants. (1990) (33)
- Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure. (1957) (32)
- Inhibition of protease activity in purulent sputum by DNA. (1967) (31)
- Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease. (1982) (31)
- Inhibition of leukocytic elastase from purulent sputum by alpha 1 -antitrypsin. (1972) (30)
- Influence of Deoxyribonucleic Acid Content on the Proteolysis of Sputum and Pus (1962) (30)
- Measurement of sputum viscosity in a cone-plate viscometer. II. An evaluation of mucolytic agents in vitro. (1968) (28)
- An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis. (1986) (28)
- Low blood pressure in young adults with cystic fibrosis: an effect of chronic salt loss in sweat? (1975) (28)
- Antitrypsin deficiency and abnormal protease inhibitor phenotypes. (1973) (28)
- Enzymes in sarcoidosis. Angiotensin-converting-enzyme (ACE). (1989) (26)
- Lymphadenopathy in an inner-city population consisting principally of intravenous drug abusers with suspected acquired immunodeficiency syndrome. (1988) (26)
- Aryl hydrocarbon hydroxylase in bronchogenic carcinoma. (1978) (26)
- Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia. (1995) (26)
- α1‐Antitrypsin deficiency in severe psoriasis (1985) (25)
- SUBSTRATE SPECIFICITY OF PROTEASE ACTIVITIES IN PURULENT SPUTUM. (1965) (23)
- Molecular abnormality of PI S variant of human alpha1-antitrypsin. (1977) (23)
- Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. (1993) (22)
- THE INDUCTION OF PROTEOLYSIS IN PURULENT SPUTUM BY IODIDES. (1964) (21)
- Heat lability of alpha1-antitrypsin variants. (1973) (20)
- Proteolytic enzyme activity and the role of desoxyribose nucleic acid (DNA) in cystic fibrosis sputum. (1963) (19)
- Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency. (1974) (18)
- Enzymatic dissolution of pulmonary secretions. An in vitro study of sputum from patients with cystic fibrosis of pancreas. (1962) (18)
- Involvement of leukocytic proteases in emphysema and antitrypsin deficiency. (1973) (17)
- Increased Kallikrein Content of Saliva from Patients with Cystic Fibrosis of the Pancreas: A Theory for the Pathogenesis of Abnormal Secretions (1969) (17)
- α1‐Antitrypsin deficiency in twins and parents‐of‐twins (1979) (16)
- Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis. (1989) (16)
- Serum Angiotensin-Converting Enzyme for Diagnosis and Therapeutic Evaluation of Sarcoidosis1–3 (2015) (15)
- Measurement of sputum viscosity in a cone-plate viscometer. I. Characteristics of sputum viscosity. (1968) (15)
- A role for intermediate, heterozygous alpha 1-antitrypsin deficiency in obstructive lung disease. (1990) (15)
- Pulmonary Plasminogen-Activator Activity in Hyaline Membrane Disease: A Reevaluation on Human, Bovine, and Rabbit Fibrin Substrates (1969) (13)
- Intermediate alpha1-antitrypsin deficiency resulting from a null gene (M-phenotype). (1976) (12)
- Fibrinolytic Activity of Arterial Tissues (1961) (12)
- Colonoscopic features of simvastatin-induced colitis suggest ischemia as an etiologic mechanism. (2005) (11)
- Clinical syndromes associated with deficient fibrinolytic activity of the lung. II. Cystic fibrosis of the pancreas. (1960) (11)
- Cyclic Fluctuation of Sweat Electrolytes in Women: Effect of Polythiazide Upon Sweat Electrolytes (1966) (10)
- Cyclic fluctuation of sweat electrolytes in women. (1966) (10)
- Carboxypeptidase B-like activity and C3 in cystic fibrosis. (1975) (10)
- Presence of a serum hemagglutinin (lectinlike factor) in cystic fibrosis homozygotes and heterozygotes. (1981) (10)
- ALPHA‐1 ANTITRYPSIN DEFICIENCY IN A PATIENT WITH WIDESPREAD PRURIGO NODULARIS (1991) (10)
- Pseudoclubbing in a patient with sarcoidosis of the phalangeal bones. (1983) (9)
- Twinning as a heterozygous advantage for alpha1-antitrypsin deficiency. (1978) (9)
- Age-related decrease in serum angiotensin converting enzyme activity: the role of thyroidal status and food intake. (1990) (9)
- Childhood cirrhosis associated with alpha-1-antitrypsin deficiency. A genetic, biochemical, and morphologic study. (1975) (9)
- In vitro evaluation of the mucolytic action of urea. (1967) (9)
- Heterozygous MZ alpha 1-antitrypsin deficiency in liver disease. (1981) (8)
- Simplified alpha1-antitrypsin phenotyping by immunofixation of acid-starch gels. (1976) (8)
- Inhibition of trypsin by deoxyribonucleic acid. (1965) (8)
- Plasma arginine esterase activity in cystic fibrosis. (1974) (8)
- Abnormal response of cultured lymphocytes to phytohemagglutinin and autologous serum in cystic fibrosis. (1977) (8)
- A new "double ring" screening test for alpha1-antitrypsin variants. (1973) (7)
- Racial distribution of alpha1-antitrypsin variants among junior high school students. (1976) (7)
- Lectin-like factor and co-factor in serum from cystic fibrosis heterozygotes. (1984) (6)
- Detection of a lectin in the blood of cystic fibrosis homozygotes and heterozygotes. (1979) (6)
- alpha 1-Antitrypsin deficiency in severe psoriasis. (1985) (6)
- Frequency of Heterozygous and Homozygous Alphax1-Antitrypsin Deficiencies in Patients with Pulmonary Emphysema. (1969) (6)
- The fibrinolytic enzyme defect of hyaline membrane disease. (1961) (6)
- Effect of converting enzyme inhibitors on serum ACE test. (1990) (6)
- The multiple causes of alpha1-antitrypsin deficiency. (1975) (5)
- Serum angiotensin converting enzyme levels in patients with alpha1-antitrypsin variants☆ (1986) (5)
- Intermediate alpha 1-antitrypsin deficiency with apical lung bullae and spontaneous pneumothorax. Presence of a Z variant in an American black. (1991) (5)
- Interference with alpha-antitrypsin studues in stored serum by presumed bacterial proteases. (1975) (4)
- Serum angiotensin-converting-enzyme in rabbits with and without pulmonary granulomatosis. Granulomatosis induced with complete-Freund's-adjuvant or BCG. (1986) (4)
- Ethacrynic acid with packed red cells. (1971) (4)
- Material isolated from normal and variant human liver that immunologically crossreacts with alpha1-antitrypsin. (1974) (3)
- Effect of menses, estrogens and hemolysis on a serum-lectin-like factor in cystic fibrosis. (1989) (3)
- Intermediate antitrypsin deficiency. (1990) (3)
- Hyaline-membrane formation and pulmonary plasminogen-activator activity in various strains of mice. (1967) (3)
- Inherited Diseases of the Lung (1988) (3)
- Racial Distribution of α1-Antitrypsin Variants among Junior High School Students1 (2015) (3)
- Angiotensin-converting enzyme in nonpulmonary sarcoidosis (1992) (3)
- Is There a Venoarterial Difference in α-Antitrypsin Levels? (1974) (3)
- Ibuprofen in patients with cystic fibrosis. (1995) (2)
- Augmentation Therapy in α1-Antitrypsin Deficiency (2001) (2)
- Screening for alpha 1-antitrypsin deficiency. (1973) (2)
- Alpha 1 -antitrypsin deficiency. (1973) (2)
- α1-Antitrypsin Deficiency and Emphysema (1970) (2)
- Serum angiotensin converting enzyme levels in patients with alpha 1-antitrypsin variants. (1986) (2)
- Assay of a urinary CF-lectin factor as a second diagnostic test for cystic fibrosis. (1990) (2)
- Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Ionic enhancement of plasminogen activator activity. (1968) (2)
- More on antitrypsin activity in lung disease. (1970) (2)
- Serum angiotensin-converting enzyme, transcobalamin and lysozyme in normal and lepromatous armadillos. (1979) (1)
- Angiotensin-converting enzyme and pulmonary sarcoidosis. (1981) (1)
- α 1 -Antitrypsin Deficiency (1970) (1)
- Lymphocytic acid-hydrolases and response to mitogens in cystic fibrosis. (1979) (1)
- Emphysema vs asthma with antitrypsin deficiency. (1989) (1)
- Aids in Screening for Heterozygous Alpha1-Antitrypsin Deficiency. (1970) (1)
- Serum trypsin inhibitors in coal miners. (1971) (1)
- The mechanisms of antitrypsin deficiency an their role in the pathogenesis of pulmonary emphysema (1975) (1)
- FIBRINOLYSIN, FIBRIN AND HYALINE MEMBRANES. (1963) (1)
- ALPHA 1-ANTITRYPSIN PHENOTYPES AND BRONCHIAL ASTHMA. AUTHORS' REPLY (1994) (1)
- Relative orientation of the ciliary central pair in the immotile cilia syndrome. (1987) (1)
- Value of antitrypsin screening. (1977) (0)
- Material Isolated from Normal and Variant Human Liver that Immunologically Crossreacts with Alpha 1-Antitrypsin ( pulmonary emphysema / liver cirrhosis / trypsin inhibition / antitrypsin deficiency ) (0)
- Low Blood Pressure in Young Adults with Cystic Fibrosis (2020) (0)
- A New Deficient Variant of α1-Antitrypsin (Mduarte) (2015) (0)
- This inherited deficiency can lead to a devastating form of emphysema. (1975) (0)
- CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. (1963) (0)
- Hyaline membrane disease and antitrypsin deficiency. (1970) (0)
- Alpha(1)-antitrypsin deficiency. (1973) (0)
- Abstract No. 321 EE: Identification and Embolization of Vascular Loops Prior to Catheter-Directed Treatment of Primary and Secondary Hepatic Malignancies (2009) (0)
- Theophylline once-a-day dosage. (1986) (0)
- Measurement of Sputum Viscosity in a Cone-Plate Viscometer1 (2015) (0)
- Alpha-1-antitrypsin deficiency. (1970) (0)
- Sequence of Authors' Names In Articles (1970) (0)
- α1-Antitrypsin Phenotypes and Bronchial Asthma-To the Editor (1994) (0)
- Pulmonary hyaline membrane disease. Internist's point of view. (1960) (0)
- Measurement of AIpha1-Antitrypsin inSerum, by Immunodiffusion andby Enzymatic Assay (1974) (0)
- A CF-lectin factor in amniotic fluid from pregnancies at risk for cystic fibrosis. (1991) (0)
- The source of a minor alpha 1-antitrypsin in variant serum. (1976) (0)
- The detection of cross-reacting material for alpha-antitrypsin in liver extracts by acid-starch electrophoresis. (1975) (0)
- A New “Double Ring” Screening Test for α1 -Antitrypsin Variants1–4 (2015) (0)
- Alpha 1-antitrypsin deficiency and emphysema. (1970) (0)
- Letter: Fibrinolytic activity in hyaline membrane disease. (1973) (0)
- Screening for Heterozygous Alpha1-Antitrypsin Deficiency (2020) (0)
- CLINICAL SPECTRUM OF ALPHA1-ANTITRYPSIN DEFICIENCY (1975) (0)
- Plasma Arginine Esterase Activity in Cystic Fibrosis1,2 (2015) (0)
- α1-ANTITRYPSIN AND EMPHYSEMA (1979) (0)
- Alpha 1 -antitrypsin and pepsin inhibition. (1971) (0)
- LETTER TO THE EDITOR (1973) (0)
This paper list is powered by the following services: